Answers are grounded in this paper and cite their sources.
In patients with COPD with CVD or risk factors for CVD, exacerbations confer an increased risk of subsequent CVD events, especially in hospitalized patients and within the first 30 days after exacerbation. Patients and clinicians should have heightened vigilance for early CVD events after AECOPD. Clinical trial registered with www.clinicaltrials.gov (NCT 01313676).
No takes yet. Share an insight, caveat, or question.
Kunisaki et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: